An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
DermTech to Present at the William Blair Growth Stock Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
DermTech, Inc. (NASDAQ: DMTK) announces management's presentation at the William Blair Growth Stock Conference on June 8, 2022, at 2:00 p.m. CT. The presentation will be accessible via a live webcast on DermTech's investor relations page, with a replay available for 90 days. DermTech specializes in precision dermatology, focusing on non-invasive skin genomics to enhance individualized care and early skin cancer detection. Their innovative products utilize Smart Stickers for genomic analysis of skin samples.
Positive
None.
Negative
None.
LA JOLLA, Calif.--(BUSINESS WIRE)--
DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that management is scheduled to present at the William Blair Growth Stock Conference on Wednesday, June 8, 2022 at 2:00 p.m. CT. A live webcast of the presentation will be available on the investor relations section of DermTech's website at https://investors.dermtech.com/news-events/events. A replay of the webcast will be archived for 90 days following the conference.
About DermTech
DermTech is a leading genomics company in dermatology and is creating a new category of medicine, precision dermatology, enabled by its non-invasive skin genomics platform. DermTech’s mission is to improve the lives of millions by providing non-invasive precision dermatology solutions that enable individualized care. DermTech provides genomic analysis of skin samples collected non-invasively using our Smart StickersTM. DermTech markets and develops products that facilitate the early detection of skin cancers and is developing products that assess inflammatory diseases and customize drug treatments. For additional information, please visit DermTech.
